Clinical Trials in San Francisco

Showing 2501-2520 of 6,211 trials

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

NCT02214160

The primary objective of this study is to evaluate the long-term safety and efficacy of UX007 in participants with LC-FAOD. The secondary objectives of this study are to evaluate the effect of UX007 on energy metabolism in LC-FAOD and evaluate the impact of UX007 on clinical events associated with LC-FAOD.

Carnitine Palmitoyltransferase (CPT I or CPT II) DeficiencyVery Long Chain Acyl-CoA Dehydrogenase (VLCAD) DeficiencyLong-chain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency+2 more

Ultragenyx Pharmaceutical Inc94 participantsStarted Dec 2014

San Francisco, California, United States • Washington D.C., District of Columbia, United States • Tampa, Florida, United States +8 more locations

COMPLETEDNA< 1 mile

Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy

NCT01121107

The purpose of this clinical study is to evaluate the safety and clinical effectiveness of use of a physician-directed, patient self-management system, guided by left atrial pressure measurements, for use in patients with heart failure. The system allows patients to adjust their HF medications daily based on a physician-directed prescription plan and their current HF status, similar to the manner in which diabetes patients manage their insulin therapy. The goal of the LAPTOP-HF study is to demonstrate reductions in episodes of worsening heart failure (HF) and hospitalizations in patients who are managed with the left atrial pressure (LAP) management system (treatment group) versus those who receive only the current standard of care (control group).

Heart Failure

Abbott Medical Devices486 participantsStarted Apr 2010

Phoenix, Arizona, United States • Fullerton, California, United States • Glendale, California, United States +61 more locations

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy

Find Trials by Condition in San Francisco

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG

Pilot Study of Peer-Supported Online Problem-Solving Program

A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD

AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines

A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis

A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)

FreeStyle Libre 3 Continuous Glucose Monitoring System

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

Look AHEAD: Action for Health in Diabetes

EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation

Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks